0001104659-22-008949.txt : 20220128 0001104659-22-008949.hdr.sgml : 20220128 20220128151428 ACCESSION NUMBER: 0001104659-22-008949 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220128 FILED AS OF DATE: 20220128 DATE AS OF CHANGE: 20220128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCNAB JAMES R CENTRAL INDEX KEY: 0001190126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13341 FILM NUMBER: 22568226 MAIL ADDRESS: STREET 1: C/O CURIS, INC STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910267 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502444990 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 4 1 tm221868-6_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-01-28 0 0000910267 TITAN PHARMACEUTICALS INC TTNP 0001190126 MCNAB JAMES R 310 BROAD STREET CHARLESTON SC 29401 1 0 0 0 Common Stock 2022-01-28 4 J 0 51021 A 51021 I By JT Pharma Common Stock 1669 D Represents $50,000 of shares issued to JT Pharmaceuticals, Inc. ("JT") as a milestone payment under the October 2020 asset purchase agreement. Mr. McNab is a principal of JT and has voting and dispositive control of such shares. /S/ James R. McNab 2022-01-28